Phase 3 is the most complex layer of the Tempered protocol. Hormonal optimization, peptides, metabolic tools, cardiovascular support — multiple interventions running simultaneously on a body that has already been built through Phase 1 and 2 work. The lab work that was important in Phase 2 becomes critical here. Not because something is necessarily going wrong, but because the only responsible way to run a sophisticated protocol is to know what the data is telling you at regular intervals.

In Phase 2, labs were validating lifestyle work — confirming that training, nutrition, sleep, and stress management were moving markers in the right direction. In Phase 3, labs serve a different and more active function. They are the feedback mechanism for a complex protocol that requires ongoing calibration. The principle from Article 14 still applies: the labs inform, how you feel confirms. But the stakes of ignoring what the labs show are higher at this level.

This article covers what to monitor, how often, how to interpret what you’re seeing — and critically, how to avoid the misinterpretations that send men chasing problems that aren’t there.

How Often: The Monitoring Cadence That Works

The right monitoring frequency for Phase 3 follows a clear logic: more often when something is new or changing, less often when the protocol is stable and you have confidence in your baseline.

Baseline before starting anything new: Before adding any new compound, adjusting a hormone dose, or making a significant protocol change, run a full panel. This is your reference point. Without it, you can’t attribute changes in your markers to any specific intervention.

Eight weeks after any protocol change: Most hormonal and metabolic adaptations require six to eight weeks to stabilize. Testing too early gives you a snapshot of the transition rather than the destination. Eight weeks after a dose adjustment, a new compound, or any meaningful protocol change is the right window for the next draw.

Every four months on a stable protocol: The four-month recalibration rhythm is where most well-run Phase 3 protocols settle. Long enough to see real trends, frequent enough to catch anything that needs adjusting before it compounds. This cadence also maps well to the quarterly rhythm of life — it’s a manageable habit rather than a constant medical exercise.

Any time something feels meaningfully off: Labs are not just a scheduled exercise. If something changes — energy, sleep, mood, libido, recovery — in a way that persists beyond a week or two, draw before the next scheduled date. Your subjective experience is data. The labs help you understand what’s driving it.

The Full Phase 3 Panel: What to Run

A standard annual physical does not cover Phase 3 monitoring. The panel below represents what a man running a serious optimization protocol should be tracking. Not every marker needs to be run every time — but all of them should be in your baseline and revisited at appropriate intervals.

Hormonal:

Total and free testosterone, estradiol (E2), LH and FSH, SHBG, prolactin, DHT, progesterone, DHEA-S, cortisol. On TRT, LH and FSH will be suppressed — that is expected. IGF-1 is particularly relevant for men running GH-related protocols.

Metabolic and cardiovascular:

Full lipid panel including ApoB and Lp(a) for the complete cardiovascular picture, fasting glucose, fasting insulin, HbA1c, homocysteine, hsCRP, complete metabolic panel.

Blood and organ function:

CBC with differential — including lymphocyte count, which is discussed in detail below. Liver enzymes (ALT, AST, GGT), kidney function (creatinine, BUN, eGFR), uric acid.

Thyroid:

TSH, free T3, free T4. Thyroid function interacts directly with hormone optimization and is frequently overlooked in Phase 3 monitoring.

Additional markers:

Vitamin D, magnesium, zinc, ferritin, PSA (critical baseline and ongoing for men on TRT).

Understanding Hormone Variability: Why Single Readings Mislead

One of the most important concepts in Phase 3 lab monitoring is also one of the most frequently misunderstood: hormone levels move. Not because something is wrong. Because that is how hormonal physiology works.

A testosterone draw at 7am after a full night of quality sleep will produce a meaningfully different number than the same man drawing at 2pm after a hard training week and two nights of disrupted sleep. Cortisol affects testosterone. Hydration status affects plasma volume and therefore concentration. The lab itself — different analyzers, different reference ranges, different handling protocols — introduces variation. A man who sees his testosterone come back 15% lower than his previous draw and immediately concludes something is wrong has drawn the wrong conclusion from normal biological noise.

This is why the Tempered approach to labs is always trends over time, not reactions to single readings. One data point is not a pattern. Three or four draws over twelve months, taken under reasonably consistent conditions, start to tell a real story.

The TRT arc deserves specific attention here because it is where variability causes the most confusion. A man who starts TRT and draws labs at eight weeks will often see elevated testosterone and free testosterone numbers — sometimes significantly above his eventual steady state. The body is still adapting. SHBG is adjusting. The hormonal system is recalibrating to exogenous testosterone in ways that take months to fully settle. Four months in, those numbers frequently drop to the actual working level — the real steady state the protocol produces.

This is not a failure. This is physiology. The right response at that four-month draw is not alarm — it is assessment. How do you feel at this level? Is energy, libido, mood, and recovery where you want it? If the answer is yes and the numbers are in a functional range, the protocol is working. If the subjective experience is not where it should be and the numbers are at the low end of the range, a conversation with your provider about dose titration is appropriate. The labs inform. How you feel confirms.

Trends over multiple draws tell the truth. Single readings tell you what was happening on one particular morning under conditions you may not fully control.

Reading the Hormonal Picture on TRT

Men on TRT should understand what their labs are expected to show so they can interpret results accurately rather than reactively.

Testosterone levels: Should be stable and consistent draw to draw when the protocol is dialed in. Large swings suggest a dosing or timing issue worth discussing with your provider.

LH and FSH: Will be near zero on TRT. This is expected — exogenous testosterone signals the hypothalamus to reduce its own production signal. This is the suppression that HCG works against to maintain testicular function. Near-zero LH and FSH on TRT is not a problem. It is confirmation that the protocol is doing what it is supposed to do.

SHBG: Sex hormone binding globulin affects how much testosterone is actually bioavailable. High SHBG means more testosterone is bound and unavailable. Low SHBG means more is free. Understanding your SHBG trend helps explain why free testosterone numbers may not move proportionally with total testosterone adjustments.

IGF-1: The most directly relevant marker for men running GH-related protocols. IGF-1 reflects GH pathway activity over the preceding weeks and is the primary feedback marker for GH optimization.

Estradiol: The Number That Sends Men Off the Rails

Estradiol management is one of the most commonly mishandled aspects of TRT monitoring and deserves a dedicated section because the errors go in a predictable direction: men see an elevated E2 reading, find alarming reference ranges online, and reach for an aromatase inhibitor before they need one.

The reference ranges for estradiol on most standard lab reports are built for the general male population — a population that is, on average, increasingly unwell. A man on TRT running higher total and free testosterone will aromatize more and will run higher E2. That is not dysfunction. That is the expected downstream consequence of more substrate for aromatization.

The Tempered principle on E2 is consistent: treat symptoms, not numbers. Water retention that won’t resolve, mood instability, emotional volatility, libido decline, sleep disruption, rising blood pressure — these are the signals that E2 management may be warranted. An elevated number on a lab report in the absence of those symptoms is not a call to action. Crashing E2 with aggressive AI use produces its own set of problems — joint pain, low libido, mood disruption, and metabolic consequences — that are often worse than running E2 slightly elevated. The goal is balance informed by symptoms, not a number on a reference range.

Liver and Kidney Monitoring: Why It Matters More in Phase 3

The additional metabolic load of a complex Phase 3 protocol makes organ function monitoring more important than it was in Phase 1 and 2. This is not fearmongering — most men running well-designed protocols show normal or improved organ function markers over time. It is responsible monitoring that catches anything meaningful before it becomes a problem.

Liver enzymes (ALT, AST, GGT): Mild elevations are common and often transient — hard training, alcohol, even intense exercise in the days before a draw can elevate ALT and AST temporarily. Persistently elevated liver enzymes, or elevations beyond two to three times the upper limit of normal, warrant investigation and protocol review with your provider.

Kidney function (creatinine, BUN, eGFR): Particularly relevant for men using creatine, running high protein intake, or using compounds that affect renal blood flow. Creatinine is also influenced by muscle mass — a more muscular man will run higher creatinine at baseline, which matters for interpreting results accurately. eGFR provides a more complete picture of actual filtration function.

Cardiovascular Markers: The Full Picture

The standard lipid panel — total cholesterol, LDL, HDL, triglycerides — is the floor, not the ceiling, of cardiovascular monitoring. The markers that add meaningful predictive value beyond the basic panel:

ApoB: Apolipoprotein B is the most predictive cardiovascular risk marker available and the one most men have never had tested. Each LDL and VLDL particle carries one ApoB molecule — ApoB measures particle count directly, which is more predictive of cardiovascular risk than LDL cholesterol alone. This should be in every Phase 3 panel.

Lp(a): Lipoprotein(a) is genetically determined and largely unresponsive to lifestyle interventions. It is important to know because it establishes a cardiovascular risk baseline that is independent of everything else you do. A man with elevated Lp(a) needs to know that and factor it into his cardiovascular protocol.

Homocysteine: An independent cardiovascular risk factor that responds well to B vitamin supplementation — B6, B12, and folate specifically. Almost never included in standard panels. Almost always worth adding.

hsCRP: High-sensitivity C-reactive protein measures systemic inflammation, which is a direct cardiovascular risk factor independent of lipid levels. Men running the full Tempered protocol typically see hsCRP improve meaningfully as lifestyle, nutrition, and sleep come together.

Men running Phase 3 protocols — particularly TRT and GLP use alongside the cardiovascular supplement stack — typically see these markers improve over time. Documenting that improvement is both medically useful and motivating. The labs become evidence that the protocol is working.

Lymphocyte Count: The Immune Marker Most Men Ignore

The CBC (complete blood count) is a standard panel most men have had run at some point. What most men don’t do is pay attention to the differential — the breakdown of white blood cell types. Lymphocyte count, in particular, is worth understanding.

Lymphocytes are the immune system’s precision force: T cells, B cells, and natural killer cells that coordinate targeted immune responses. They are the difference between an immune system that responds appropriately and one that is sluggish, overreactive, or compromised.

Chronically low lymphocyte count — lymphopenia — in an otherwise healthy man is a signal worth taking seriously. The most common drivers in the optimizing man’s context: chronic overtraining without adequate recovery, persistent sleep deficits, chronic psychological stress, and nutritional deficiencies. These are the same variables the Tempered Foundation addresses — which is part of why men who build the foundation see immune resilience improve alongside everything else.

The longevity angle on lymphocytes is emerging and worth understanding. Lymphocyte count and the ratio of lymphocytes to other white blood cell types is increasingly recognized as a meaningful biomarker of biological aging and immune resilience. A man with a strong lymphocyte count relative to his chronological age has an immune system that is functioning younger than his years. That is not a vanity metric — it is a direct measure of how well the body can defend itself and recover from challenge.

When you get your CBC, look at the differential. Know your lymphocyte count and trend it over time alongside everything else.

PSA: The TRT Conversation Every Man Needs to Have

Prostate-specific antigen testing is non-negotiable for men on TRT. The evidence that TRT causes prostate cancer is not strong — the relationship is more nuanced than the historical fear suggested. But TRT does stimulate prostate tissue, and a man who already has an undetected prostate issue when he starts TRT may see it progress more quickly.

The most important PSA principle: establish a baseline before starting TRT, and trend it from there. A single PSA reading in isolation tells you relatively little. The trend line — how the number moves over successive draws — tells you what matters. A stable PSA over two years of TRT is reassuring. A PSA that doubles in twelve months warrants investigation regardless of the absolute number.

Working With Your Provider: What Good Lab Review Looks Like

Phase 3 monitoring requires a provider relationship that goes beyond ordering tests. The right provider interprets the full panel in the context of the protocol being run — not against standard reference ranges built for a general population. They adjust based on trends across multiple draws, not single readings. They understand the interaction between the compounds being run and the markers being monitored.

What to bring to every lab review: your previous results for comparison, your current protocol in full detail, and your subjective experience since the last draw. The labs inform. How you feel confirms. A good provider uses both.

If your provider looks at your labs in isolation, without reference to your protocol or your subjective experience, that is a signal. Phase 3 monitoring done correctly is a collaborative, contextual process — not a checkbox exercise.

FROM THE FIELD

My monitoring cadence is every four months on a stable protocol, with additional draws any time I make a meaningful change. That rhythm gives me enough data points to see real trends without turning lab work into a full-time job.

I started this journey with lipid panels, glucose numbers, and metabolic markers that were elevated and moving in the wrong direction. Every marker I track now — hormonal, metabolic, cardiovascular, organ function — has improved. Some dramatically. I’m not going to publish the specific numbers, but the arc is real and it is the direct result of the full protocol working together: the Foundation built first, Phase 3 tools layered on top, consistent monitoring informing adjustments along the way.

One thing I’d emphasize from experience: the four-month rhythm matters. The men I know who check labs every six weeks are often reacting to noise rather than signal. The men who go a year between draws are flying blind. Four months is long enough to see where things are actually settling and short enough to catch anything that needs attention before it compounds.

On hormone variability specifically — this is something I’ve lived. Early in my TRT protocol my numbers looked one way. Four months later, as my body settled into steady state, they looked different. That adjustment period is real and it is normal. The question at that four-month mark is never just ‘what do the numbers say’ — it is ‘how do I feel at this level and does anything need adjusting.’ The labs and the subjective experience together tell the story. Neither one alone is enough.

The Bottom Line

Phase 3 is the most sophisticated layer of the Tempered protocol and it requires the most sophisticated monitoring approach. The full panel, run at the right intervals, interpreted in the context of the full protocol and subjective experience, is what separates deliberate optimization from guesswork.

The goal is not perfect numbers on every marker. The goal is a clear, consistent picture of how the protocol is performing over time — and the data to make informed adjustments when something needs attention. That is what responsible Phase 3 monitoring looks like.

→ Phase 2 lab work: Article 14 — The Lab Work Every Man Over 40 Should Be Getting

→ Phase 3 overview: Article 16 — The Second Peak

→ TRT Primer: Article 17 — Testosterone Replacement Therapy: Starting Right

→ Heart health and cardiovascular monitoring: Article 23 Heart Health: Tadalafil and the Cardiovascular Stack